Biogenesis Articles
Cylene closes $44M financing
29 January 2007
Resveratrol reduces fat and boosts endurance by activating SIRT1
27 November 2006
MorphoSys sees 100% 1st-qtr income rise
22 May 2006
Morphosys: 73% revenue rise in 1st half
8 August 2005
MorphoSys revenues leap 72% in 1st qtr
9 May 2005
MorphoSys sees 2004 revenues leap 44%
21 February 2005
MorphoSys acquires Biogenesis for $9.9M
24 January 2005
Showing 1-8 of 8 articles
- 1
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Pfizer to split-off remaining 80% interest in Zoetis
